LSL Pharma Group Inc. (TSXV:LSL)
0.3200
-0.0100 (-3.03%)
At close: Aug 28, 2026
LSL Pharma Group Company Description
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally.
It offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, as well as natural health products in sachets, capsules, loose powder, blister packs, and liquids for pharmacy banners and hospitals.
The company is headquartered in Boucherville, Canada.
LSL Pharma Group Inc.
| Country | Canada |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 252 |
| CEO | Francois Roberge |
Contact Details
Address: 540, d’Avaugour Street Boucherville, QC J4B 0G6 Canada | |
| Phone | 514-664-7700 |
| Website | groupelslpharma.com |
Stock Details
| Ticker Symbol | LSL |
| Exchange | TSX Venture Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Francois Roberge | President, Chief Executive Officer and Director |
| Marc Boudreault | Vice-President of Communications |
| Luc Mainville M.B.A. | Chief Financial Officer and Senior Vice President |
| Alain R. Dugal | Chief Operating Officer and Executive Vice President |
| Guy Paul Allard | Vice President, Legal Affairs and Corporate Secretary |